GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (LTS:0OIR) » Definitions » E10

Alk-Abello AS (LTS:0OIR) E10 : kr0.94 (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Alk-Abello AS E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Alk-Abello AS's adjusted earnings per share data for the three months ended in Dec. 2024 was kr0.780. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr0.94 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Alk-Abello AS's average E10 Growth Rate was 38.90% per year. During the past 3 years, the average E10 Growth Rate was 27.70% per year. During the past 5 years, the average E10 Growth Rate was 12.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Alk-Abello AS was 27.70% per year. The lowest was -51.70% per year. And the median was -1.20% per year.

As of today (2025-03-24), Alk-Abello AS's current stock price is kr149.45. Alk-Abello AS's E10 for the quarter that ended in Dec. 2024 was kr0.94. Alk-Abello AS's Shiller PE Ratio of today is 158.99.

During the past 13 years, the highest Shiller PE Ratio of Alk-Abello AS was 379.56. The lowest was 8.09. And the median was 168.18.


Alk-Abello AS E10 Historical Data

The historical data trend for Alk-Abello AS's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello AS E10 Chart

Alk-Abello AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.48 0.84 1.06 0.94

Alk-Abello AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.06 0.93 0.83 0.81 0.94

Competitive Comparison of Alk-Abello AS's E10

For the Biotechnology subindustry, Alk-Abello AS's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alk-Abello AS's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alk-Abello AS's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alk-Abello AS's Shiller PE Ratio falls into.



Alk-Abello AS E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alk-Abello AS's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.78/118.9000*118.9000
=0.780

Current CPI (Dec. 2024) = 118.9000.

Alk-Abello AS Quarterly Data

per share eps CPI Adj_EPS
201503 0.452 100.200 0.536
201506 0.250 100.300 0.296
201509 0.300 100.200 0.356
201512 0.698 99.800 0.832
201603 0.600 100.200 0.712
201606 0.350 100.600 0.414
201609 0.200 100.200 0.237
201612 0.176 100.300 0.209
201703 0.010 101.200 0.012
201706 -0.005 101.200 -0.006
201709 -0.120 101.800 -0.140
201712 -0.739 101.300 -0.867
201803 0.110 101.700 0.129
201806 -0.080 102.300 -0.093
201809 -0.120 102.400 -0.139
201812 -0.677 102.100 -0.788
201903 0.205 102.900 0.237
201906 -0.310 102.900 -0.358
201909 -0.140 102.900 -0.162
201912 -0.060 102.900 -0.069
202003 0.390 103.300 0.449
202006 -0.045 103.200 -0.052
202009 -0.090 103.500 -0.103
202012 -0.142 103.400 -0.163
202103 0.580 104.300 0.661
202106 -0.100 105.000 -0.113
202109 0.170 105.800 0.191
202112 0.340 106.600 0.379
202203 0.700 109.900 0.757
202206 0.200 113.600 0.209
202209 0.200 116.400 0.204
202212 0.310 115.900 0.318
202303 0.700 117.300 0.710
202306 0.300 116.400 0.306
202309 0.500 117.400 0.506
202312 0.600 116.700 0.611
202403 1.100 118.400 1.105
202406 0.900 118.500 0.903
202409 1.000 118.900 1.000
202412 0.780 118.900 0.780

Add all the adjusted EPS together and divide 10 will get our e10.


Alk-Abello AS  (LTS:0OIR) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Alk-Abello AS's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=149.45/0.94
=158.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Alk-Abello AS was 379.56. The lowest was 8.09. And the median was 168.18.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Alk-Abello AS E10 Related Terms

Thank you for viewing the detailed overview of Alk-Abello AS's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Alk-Abello AS Business Description

Traded in Other Exchanges
Address
Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.

Alk-Abello AS Headlines

No Headlines